Nutrition, food, supplements, exercise, sleep, stress, and lifestyle research for Crohn's disease and IBD.
Page 2 of 24 · 1123 articles
This study identifies a compound that improved inflammation, barrier integrity, and microbiome/metabolite signatures in a mouse model of ulcerative colitis—areas that matter for symptom control and disease biology in...
This study highlights a potential microbiome–bile acid–immune pathway that could be relevant to ulcerative colitis and suggests a traditional herbal formula may influence that pathway in mice. Patients interested in...
People with ulcerative colitis may be interested because the study suggests a combined probiotic approach could strengthen gut bacteria functions linked to a protective metabolite (spermidine) and reduce colitis-like...
This preclinical study identifies a parasite-derived fluid that reduced inflammation, oxidative stress, and microbiome disruption in a mouse model of ulcerative colitis and in intestinal cells, pointing to possible new...
This study suggests coconut oil and its myristic acid component reduced Crohn’s-like inflammation in a mouse model via effects on the microbiome and regulatory T cells, which could point toward new dietary or adjunctive...
The study links lower vitamin D and higher TNF‑alpha with greater UC severity and with each other, suggesting these measurable biomarkers may reflect inflammation in ulcerative colitis.
PRO2 and PRO3 were recorded far more often than CDAI or HBI in routine care and correlated strongly with those clinician-scored indices, so they may be a practical way to monitor Crohn’s activity and support real-world...
Multi-omics and AI approaches could improve biomarker discovery and predictive models that matter for earlier diagnosis and personalised treatment strategies in IBD, but practical use is limited today by data and...
The study suggests a colon-targeted herbal treatment altered metabolic and immune pathways and reduced inflammation in a rat model of ulcerative colitis, which could point to new therapeutic approaches to explore for UC...
People with Crohn's disease may be interested because the paper provides molecular hypotheses linking acupuncture to immune-related pathways (neutrophils, M2 macrophages) and nominates FER as a potential...
The study explores whether people with UC in deep histologic remission can reduce or stop maintenance medications without losing remission — a question many patients and clinicians face because of medication costs, side...
An experimental mouse study suggests gastrodin may reduce colitis severity and associated anxiety/depression-like behaviours while changing gut microbiota, metabolites, and intestinal inflammation — an early preclinical...
Researchers are exploring targeted oral delivery and immune‑modulating strategies for colitis in older hosts; this study suggests a nanoparticle approach can alter T cell aging signs and the gut microbiome in mice, which...
Researchers are exploring targeted oral delivery methods to improve treatment of colitis in older individuals. If translatable, a colon-targeted nanogel that boosts regulatory T cells and favorably shifts the microbiome...
The study suggests people with IBD consumed more dietary emulsifiers than healthy controls and found initial links between higher UPF/emulsifier intake and worse IBD-related events, which could be important if diet...
Nutritional disorders in IBD (underweight/malnutrition, overweight/obesity, and muscle loss/sarcopenia) are common and affect treatment tolerance, recovery, and quality of life. Knowing how frequent these problems are...
Children with IBD can present differently than adults and may show early signs outside the gut. The special-issue papers highlight improved, less-invasive diagnostic tools and increasing use of targeted biologic...
The article discusses peptide compounds that people with Crohn’s and other IBDs are exploring for gut barrier support and inflammation — a topic many patients consider when seeking adjunctive or experimental approaches.
If true, the findings suggest that everyday chemicals (bisphenols) might influence immune pathways relevant to IBD and that RORC could be a molecular link — potentially relevant for researchers studying environmental...
People with Crohn’s or IBD often try nutritional supplements; this article surveys claims and early research about collagen peptides that some hope could support gut lining and reduce inflammation. It’s useful for...
Lifestyle factors like diet, exercise, and mental‑health support may help people with ulcerative colitis, but delivering them together is complex.
Vitamin D deficiency was very common in this IBD cohort and was linked to Crohn’s disease and female sex, which may matter because deficiency can affect bone health and immune regulation in people with IBD.
Based on the title and source metadata, this appears to be a clinical study related to Inflammatory bowel disease and Pediatrics and family. The original article is from Nutrients.
The study identifies acid ceramidase in myeloid cells as a regulator of sphingolipid metabolites and immune cell recruitment in a mouse model of chronic colitis, pointing to a possible new therapeutic target for IBD.
Understanding microbiota–neuroimmune interactions could explain why symptoms like urgency and pain persist in some people with UC and may point to new treatment strategies that go beyond conventional anti-inflammatory...
Based on the title and source metadata, this appears to be an opinion or commentary related to Inflammatory bowel disease, Fatigue, and Pain. The original article is from Translational gastroenterology and hepatology.
This study suggests a plant extract (Macleaya cordata) and its component sanguinarine reduced inflammation and improved colitis signs in mice by changing gut bacteria and macrophage activation — mechanisms relevant to...
The trial tests a naturally derived oral supplement (WPMDE2) in patients with ulcerative colitis, measuring symptoms, inflammatory markers, and quality of life—outcomes that matter to people living with IBD. Early-phase...
The study identifies ABCA1 deficiency and epithelial cholesterol accumulation as drivers of colonic injury and inflammation in a hamster model, highlighting a possible new mechanism relevant to IBD pathogenesis. That...
The report suggests fertility treatments—particularly embryo transfer/IVF—can be successful for many women with Crohn's disease or ulcerative colitis, which may reassure patients concerned about fertility after IBD or...
Fatigue affects a large share of people with IBD and often persists despite remission; understanding treatment options and the need for a broad care plan can help patients and clinicians set realistic goals and...
The paper suggests a new animal model linking syndromic albinism mutations, intestinal inflammation, and gut-microbiome changes—areas relevant to understanding IBD biology and potential microbiome-targeted interventions.
The study identifies thymoquinone as a compound that reduced inflammation and protected the intestinal barrier in a mouse colitis model, highlighting a possible new avenue for IBD drug discovery focused on the Notch...
Cure8 found this source from medpagetoday.com, but the page could not be read reliably yet. It is tagged for Inflammatory bowel disease and Diet and lifestyle. Open the original article for the full details.
The study suggests a dietary protein (ovotransferrin) can reduce colitis severity in mice by changing the gut microbiota and increasing certain secondary bile acids that lower inflammation and gut permeability.
Capsaicin is commonly consumed and acts on TRPV1, which is increased in inflamed IBD tissue; depending on dose and disease activity it may help or worsen inflammation and symptom-related pain.
MMP-2 regulates tissue remodeling and inflammation in IBD; targeting it might help prevent barrier damage, chronic inflammation, or fibrosis but requires selective approaches to avoid harming normal repair processes.
The paper suggests a specific gut bacterium and its metabolite can protect against intestinal inflammation in mice by acting on enteric neurons, revealing a new neuro-immune pathway that could inform future IBD...
This study explores a non-drug dietary supplement approach aimed at changing host–microbiome interactions after surgery — a potentially relevant prevention strategy for postoperative Crohn's disease recurrence if later...
Findings highlight cultivable gut microbiota differences in Crohn’s disease versus controls and present preliminary in vitro antimicrobial activity of two thyme essential oils—topics that may interest patients following...
Based on the title and source metadata, this appears to be a clinical study related to Inflammatory bowel disease and Mental health and quality of life. The original article is from BMC Gastroenterology.
Microbiota-derived metabolites are linked to inflammation and gut barrier function, so they could become biomarkers or therapeutic targets for Crohn’s disease and ulcerative colitis. Patients may see future tests or...
This research links a gut bacterial metabolite to modulation of an immune receptor (GPR183) that is elevated in colon/rectum of ulcerative colitis patients, suggesting a possible microbiota‑to‑immune pathway relevant to...
The review links ER stress and mitochondrial dysfunction to core IBD processes (inflammation, barrier damage, cell death) and highlights MERCs as an integrated signaling hub, suggesting new biomarker and therapeutic...
Muscle loss (myopenia) can persist in Crohn's disease even after weight recovery and clinical remission, which may affect long-term outcomes. Identifying persistent muscle depletion with body composition measures could...
The paper reports novel ibuprofen-derived compounds that reduce inflammation and restore intestinal immune balance in preclinical models of ulcerative colitis, suggesting a potential new drug-development direction that...
The study points to a specific microbiome-derived micronutrient pathway (queuosine/queuine) that appears reduced in IBD, which could help explain part of microbiome-related changes in intestinal cells and suggest new...
Physical activity is linked to general health and quality of life. If people with IBD—particularly those with more severe CD—are less active, tailored support could help improve wellbeing and manage disease-related...
